Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Traverse Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Traverse Biosciences

Traverse Biosciences

Seed

US-based Traverse Bioscience commercializes novel drugs for human and animal inflammatory diseases.

HQ
Stony Brook, NY, US
Founded
2013
Overview
Compare
Fundraising
Employees

Traverse Biosciences, based in Stony Brook, United States, focuses on commercializing novel drugs for treating inflammatory diseases in humans and companion animals. The company aims to address significant unmet medical needs in the bioscience sector, serving customers across the United States.

Traverse Biosciences has made notable strides in developing innovative treatments for inflammatory conditions. Its impact on the bioscience industry is marked by its commitment to improving health outcomes for both humans and animals.

Traverse Biosciences - Similar Companies

Travere Therapeutics logo

Travere Therapeutics

travere.com

Traversa Therapeutics logo

Traversa Therapeutics

traversathera.com

Transcera logo

Transcera

Trana Discovery logo

Trana Discovery

BridGene Biosciences logo

BridGene Biosciences

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Brii Biosciences logo

Brii Biosciences

briibio.com

TRex Bio logo

TRex Bio

trex.bio

Chase Therapeutics logo

Chase Therapeutics

Exalys Therapeutics logo

Exalys Therapeutics

Resolvyx Pharmaceuticals logo

Resolvyx Pharmaceuticals

Bioscience Pharma Partners logo

Bioscience Pharma Partners

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

Pyramid Biosciences logo

Pyramid Biosciences

HI-Bio logo

HI-Bio

hibio.com

Traverse Biosciences - Quick Facts

Who are Traverse Biosciences' competitors?

Companies similar to Traverse Biosciences include Travere Therapeutics, Traversa Therapeutics, Transcera and Trana Discovery.

When was Traverse Biosciences founded?

Traverse Biosciences was founded in 2013.

Where is Traverse Biosciences' headquarters located?

Traverse Biosciences' headquarters is located in Stony Brook, NY, US.

When was Traverse Biosciences' last funding round?

Traverse Biosciences' most recent funding round was for $500k (USD) in June 2016.

How much has Traverse Biosciences raised to-date?

As of Jun 8, 2016, Traverse Biosciences has raised a total of $600k (USD).

How many employees does Traverse Biosciences have?

Traverse Biosciences has 14 employees as of Feb 4, 2024.

Traverse Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Drugs
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 3250Manufacture of medical and dental instruments and supplies
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339116Dental Laboratories
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8070Medical And Dental Laboratories
  • 8072Dental Laboratories
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified